Picture of IGM Biosciences logo

IGMS — IGM Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

IGM Biosciences Inc reports results for the quarter ended in March - Earnings Summary

* IGM Biosciences Inc  IGMS.OQ  reported a quarterly
adjusted loss
of 83 cents​​ per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of $-1.33.  The mean expectation of nine analysts for the
quarter was for a loss of 83 cents per share. Wall Street
expected results to range from -96 cents to -75 cents per share.
    * Revenue fell 4.8% to $497.00 thousand from a year ago;
analysts
expected $759.38 thousand. 
    * IGM Biosciences Inc's reported EPS for the quarter was a
loss
of 83 cents​.
    * The company reported a quarterly loss of $49.82 million.
    * IGM Biosciences Inc shares had risen by 4.9% this
quarter and
gained 21.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for IGM Biosciences
Inc is $20.00 
This summary was machine generated from LSEG data May 10 at
11:59 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.83          -0.83          Met
 Dec. 31 2023      -1.03          -1.01          Beat
 Sep. 30 2023      -1.21          -1.04          Beat
 Jun. 30 2023      -1.43          -1.43          Met

Recent news on IGM Biosciences

See all news